217 related articles for article (PubMed ID: 28425971)
41. Expression profiling of the solute carrier gene family in chicken intestine from the late embryonic to early post-hatch stages.
Li H; Gilbert ER; Zhang Y; Crasta O; Emmerson D; Webb KE; Wong EA
Anim Genet; 2008 Aug; 39(4):407-24. PubMed ID: 18544075
[TBL] [Abstract][Full Text] [Related]
42. SLC Neurotransmitter Transporters as Therapeutic Targets for Alcohol Use Disorder: A Narrative Review.
McColl ER; Piquette-Miller M
Alcohol Clin Exp Res; 2020 Oct; 44(10):1965-1976. PubMed ID: 32862443
[TBL] [Abstract][Full Text] [Related]
43. MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells.
Yi C; Yu AM
Front Mol Biosci; 2022; 9():893846. PubMed ID: 35755805
[TBL] [Abstract][Full Text] [Related]
44. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
45. TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.
Michel ME; Wen CC; Yee SW; Giacomini KM; Hamdoun A; Nicklisch SCT
Clin Pharmacol Ther; 2023 Dec; 114(6):1293-1303. PubMed ID: 37657924
[TBL] [Abstract][Full Text] [Related]
46. Loops and layers of post-translational modifications of drug transporters.
Xu D; You G
Adv Drug Deliv Rev; 2017 Jul; 116():37-44. PubMed ID: 27174152
[TBL] [Abstract][Full Text] [Related]
47. Defining solute carrier transporter signatures of murine immune cell subsets.
Aaes TL; Burgoa Cardás J; Ravichandran KS
Front Immunol; 2023; 14():1276196. PubMed ID: 38077407
[TBL] [Abstract][Full Text] [Related]
48. Reshaping the Binding Pocket of the Neurotransmitter:Solute Symporter (NSS) Family Transporter SLC6A14 (ATB
Anderson CMH; Edwards N; Watson AK; Althaus M; Thwaites DT
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291613
[TBL] [Abstract][Full Text] [Related]
49. The Druggability of Solute Carriers.
Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
[TBL] [Abstract][Full Text] [Related]
50. SLC Transporters: Structure, Function, and Drug Discovery.
Colas C; Ung PM; Schlessinger A
Medchemcomm; 2016 Jun; 7(6):1069-1081. PubMed ID: 27672436
[TBL] [Abstract][Full Text] [Related]
51. Lysosomal solute carrier transporters gain momentum in research.
Bissa B; Beedle AM; Govindarajan R
Clin Pharmacol Ther; 2016 Nov; 100(5):431-436. PubMed ID: 27530302
[TBL] [Abstract][Full Text] [Related]
52. Systematic in silico discovery of novel solute carrier-like proteins from proteomes.
Gyimesi G; Hediger MA
PLoS One; 2022; 17(7):e0271062. PubMed ID: 35901096
[TBL] [Abstract][Full Text] [Related]
53. Amino Acid Transport Defects in Human Inherited Metabolic Disorders.
Yahyaoui R; Pérez-Frías J
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878022
[TBL] [Abstract][Full Text] [Related]
54. The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance.
Cooke A; Schwarzl T; Huppertz I; Kramer G; Mantas P; Alleaume AM; Huber W; Krijgsveld J; Hentze MW
Cell Rep; 2019 Jun; 27(11):3097-3106.e5. PubMed ID: 31189097
[TBL] [Abstract][Full Text] [Related]
55. Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters.
Li Z; Wang K; Zheng J; Cheung FS; Chan T; Zhu L; Zhou F
Pharm Biol; 2014 Dec; 52(12):1510-7. PubMed ID: 25026340
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive review of amino acid transporters as therapeutic targets.
Xia R; Peng HF; Zhang X; Zhang HS
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129646. PubMed ID: 38272411
[TBL] [Abstract][Full Text] [Related]
57. Phenotypic profiling of solute carriers characterizes serine transport in cancer.
Papalazarou V; Newman AC; Huerta-Uribe A; Legrave NM; Falcone M; Zhang T; McGarry L; Athineos D; Shanks E; Blyth K; Vousden KH; Maddocks ODK
Nat Metab; 2023 Dec; 5(12):2148-2168. PubMed ID: 38066114
[TBL] [Abstract][Full Text] [Related]
58. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
59. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
60. Analysis and update of the human solute carrier (SLC) gene superfamily.
He L; Vasiliou K; Nebert DW
Hum Genomics; 2009 Jan; 3(2):195-206. PubMed ID: 19164095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
